CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS' EQUITY (DEFICIT) (UNAUDITED) - USD ($) $ in Thousands		Total	Convertible Preferred Stock	Non-Voting Preferred Shares	Ordinary Shares		Additional Paid-in Capital	Accumulated Deficit
Beginning balance, Convertible Preferred Stock (in shares) at Dec. 31, 2024			20,000,000
Beginning balance, Convertible Preferred Stock at Dec. 31, 2024			$ 4,000
Ending balance, Convertible Preferred Stock (in shares) at Mar. 31, 2025			20,000,000
Ending balance, Convertible Preferred Stock at Mar. 31, 2025			$ 4,000
Beginning balance (in shares) at Dec. 31, 2024				0
Beginning balance at Dec. 31, 2024		$ (15,479)		$ 0	$ 1	[1]	$ 2,387	$ (17,867)
Beginning balance (in shares) at Dec. 31, 2024	[1]				1,018,604
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense		466					466
Early exercise of stock options (in shares)	[1]				811
Net loss		(15,148)						(15,148)
Ending balance (in shares) at Mar. 31, 2025				0
Ending balance at Mar. 31, 2025		$ (30,161)		$ 0	$ 1	[1]	2,853	(33,015)
Ending balance (in shares) at Mar. 31, 2025	[1]				1,019,415
Beginning balance, Convertible Preferred Stock (in shares) at Dec. 31, 2025			0
Beginning balance, Convertible Preferred Stock at Dec. 31, 2025			$ 0
Ending balance, Convertible Preferred Stock (in shares) at Mar. 31, 2026			0
Ending balance, Convertible Preferred Stock at Mar. 31, 2026			$ 0
Beginning balance (in shares) at Dec. 31, 2025		2,890		2,890
Beginning balance at Dec. 31, 2025		$ 203,012		$ 4,000	$ 28	[2]	370,793	(171,809)
Beginning balance (in shares) at Dec. 31, 2025		27,556,767			27,556,767	[2]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Parascent warrants		$ 423					423
Release of restricted stock units (in shares)	[2]				15,168
Vesting of early exercised stock options		5					5
Stock-based compensation expense		$ 3,690					3,690
Early exercise of stock options (in shares)		0
Net loss		$ (23,283)						(23,283)
Ending balance (in shares) at Mar. 31, 2026		2,890		2,890
Ending balance at Mar. 31, 2026		$ 183,847		$ 4,000	$ 28	[2]	$ 374,911	$ (195,092)
Ending balance (in shares) at Mar. 31, 2026		27,571,935			27,571,935	[2]

[1] Includes 296,104 restricted stock awards outstanding.

[2] Includes 168,215 restricted stock awards outstanding.